American business tycoon and philanthropist Bill Gates, co-chair of the Bill and Melinda Gates Foundation on Friday announced an emergency relief fund of $700,000 for the flood victims of Jammu and Kashmir.
An association of biotechnology scientists on Wednesday appealed to the Centre to approve Bt brinjal for commercial cultivation "without further delay" for the benefit of Indian farmers and consumers.
Foreign portfolio investors (FPIs) have pumped in a whopping $33.8 billion into domestic equities and debt till February 15 this fiscal year -- the highest since FY15 when it was nearly $46 billion --taking their net outstanding investments to a record $592.5 billion, as per a report. Of the total FPI assets of $592.5 billion, $537.4 billion were in equities and $51.38 billion in debt, according to the data collated by Care Ratings. The maximum holding is in financial services sector at $191.3 billion, followed by software ($76.1 billion), oil & gas ($50 billion), automobiles & auto components ($26.9 billion, pharmaceuticals & biotechnology ($22.8 billion), sovereign ($21.7 billion--debt), household & personal products ($20.2 billion), capital goods ($19.8 billion), food, beverages & tobacco ($15.7 billion) and insurance ($13.4 billion).
While financial institutions like banks not showing interest in investing in basic biotechnology research as they have long gestation periods, PE and VC funds too are not comfortable betting their money on research projects as they do not give an opportunity for a quick exit facility.
The Indian government and private firms have stepped up efforts to develop a vaccine to halt the spread of COVID-19 which has claimed over 3,700 lives with more than 1,25,000 cases in the country.
The first COVID-19 vaccine to reach phase I clinical trial is safe, well-tolerated, and capable of generating an immune response against the novel coronavirus in humans, says a new research published in The Lancet journal.
India's biotechnology industry has crossed the $1 billion mark in revenues.
Presentations were given by the Department of Science and Technology, Department of Biotechnology, Council of Scientific and Industrial Research (CSIR) and the principal scientific adviser to the government before the Parliamentary Standing Committee on Science and Technology, Environment and Climate on the Centre's COVID-19 preparedness.
Clinical trials, agri-biotech and bio-fuels are becoming opportunities. There are a lot of growth drivers and trigger points which, she said, will deliver in the next five years.
National Woman Bioscientist Awards: 2003
While Karnataka reported five new cases, Delhi and Telangana reported four each, and Gujarat reported one fresh case of the Omicron variant.
In an interview with Nandita Datta she talks about biotechnology becoming the new buzzword and what it takes to build a successful career.
The joint secretary also said a high-level task force to work on frontiers of science related to vaccines and drug testing was formed on Sunday.
The Indian biotechnology sector is poised for an exponential growth and would garner a global market share of 10 per cent in the next five years from the present one per cent.
The formula for success of farm economy is very simple -- farmers should be able to produce more from the same piece of land at reduced cost while minimising risk and be connected to market to get higher realisation for their produce, points out Siraj Chaudhry.
The foreign envoys were taken to Hyderabad over a month after the ministry of external affairs briefed over 190 heads of diplomatic missions and representatives of leading international organisations on COVID-19 related issues.
The company has received approval from the Drugs Controller General of India (DCGI) to market Itolizumab injection 25mg/5mL solution for emergency use in India for the treatment of cytokine release syndrome in moderate to severe acute respiratory distress syndrome (ARDS) due to COVID-19.
Currently, the country is using two 'made-in India' jabs -- Covishield and Covaxin -- to inoculate its billion-plus population and has administered 20 crore doses since launching the world's largest vaccination drive in mid-January. A third vaccine, Russian-made Sputnik V, has been approved by the government and is being used on a smaller scale at present.
a team led by ecologist Uma Ramakrishnan and her student Vinay Sagar from the National Centre for Biological Sciences, Bangalore, have discovered that the coat colouration and patterning which make the wild cats appear dark boil down to a single mutation
'There is no emergency of a third wave that we are rushing for booster doses.'
Med Ad News is a global pharmaceutical magazine and is regarded as one of the most respected journals in the segment.
The company has set an affordable ceiling price of USD 3 (around Rs 225) per dose, it added.
Joint Secretary in the Health Ministry Lav Agarwal claimed that India has been doing better than many other countries on the outcome ratio, which is the number of recoveries from coronavirus infection versus the number of deaths.
The Indian Institute of Science, Bangalore, invites applications from Indian nationals for the DBT-Postdoctoral Fellowship for pursuing research in the frontier areas of biotechnology and applied biology.
Mukul Jain, enrolled in Life Sciences course, has been missing since January 8.
'In case of shortage of other raw material, like filters and bags, one can try to develop another vendor. However, for chemicals as critical as adjuvants, this is not possible'
Shahid Jameel, recipient of Shanti Swarup Bhatnagar Prize for Science and Technology, also said that the country had already reached community transmission a long time ago.
India's export revenue from biotechnology grew by 47 per cent to reach to 1.2 billion dollars in the financial year ended March 2007, a survey said.
Today, an engineer from an average college can easily land an IT job. What about the biotech graduate, asks Rashmi Bansal?
This apart, to further increase capacities, Bharat Biotech has partnered with Indian Immunologicals (IIL) to manufacture the drug substance for Covaxin. The technology transfer process is underway and IIL has the 'capabilities and expertise' to manufacture the inactivated viral vaccines at commercial scale.
While virologists say theoretically the vaccine that works on Delta should work on the Delta Plus variant as well, more research is needed.
Institute of Bioinformatics and Applied Biotechnology, Bangalore, invites applications for its Post-graduate Diploma in Bioinformatics and Laboratory Course in Biotechniques programmes.
